Discharge planning – reducing admissions/re- admissions Jo Clarke, CPPE tutor 1.

Slides:



Advertisements
Similar presentations
Community Pharmacy – Call to Action Derbyshire / Nottinghamshire Area Team.
Advertisements

Palliative Care Clinical Care Programme
Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.
How do you get nursing staff involved?
Walsall Healthcare NHS Trust Medicines Management.
The Challenges for Medicines Optimisation
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
IMPACTS OF PHARMACIST’S ROLES ON REDUCING READMISSION RATE AND PROMOTING PATIENT SAFETY IN PEDIATRIC CARDIAC PATIENTS Manita Suriyarangsee Monwarat Laohajeeraphan.
Medicines Optimisation How can data help us to get it right?
1 “Medicines use review conducted in community pharmacy" Professor Ian Chi Kei Wong Department of Health Public Health Career Scientist The School of Pharmacy.
Section Title Hospital referral to community Pharmacy An Innovators’ toolkit to support the NHS in England.
Medication Safety Standard 4 Part 3 – Documentation of Patient Information, Continuity of Medication Management Margaret Duguid, Pharmaceutical Advisor.
THE ROLE OF THE HEART FAILURE SPECIALIST NURSE NHS Grampian Heart Failure Nurses November 2008.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
The London Older People Service Development Program (LOPSDP) The ‘Medicines Management’ Project (January to July 2003) Lelly Oboh Project Co-ordinator.
Nurse-led Long term Conditions Management
1. How can we promote pharmacies and the full service available? Think about: How the NHS works with Local Authorities to enhance the role of community.
MEDICINES and Older People Hira Singh Prescribing Adviser (Middlesbrough PCT and Redcar & Cleveland PCT Medicines Management Team) March 2008.
Long Term Conditions Overview Tuesday, 22 May 2007 Dr Bill Mutch.
NHS General Practice Pharmacist Training Pathway (GPPTP)
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
TORFAEN MEDICATION ADMINISTRATION SCHEME Val Bessell Wendy Tyler-Batt.
Summary of ICIUM Chronic Care Track Prepared by: Ricardo Perez-Cuevas Veronika Wirtz David Beran.
A domiciliary medication review service – ‘MESH’ Su Wood – Prescribing Support Services
Welcome to February’s ETAG Su Long, Chief Officer.
Standard 4: Medication Safety Advice Centre Network Meeting Margaret Duguid Pharmaceutical Advisor February 2013.
Medicines Optimisation Presented by Sue Mulvenna Pharmacist Lead SW Strategic Clinical Networks November 2014.
SPSP Medicines Paediatric Networking Event Prepared by: David Maxwell.
Improving access to prescriptions with a practice pharmacist Dr Duncan Petty Prescribing Support Services Ltd Research Pharmacist, University of Bradford.
Medicines optimisation – a research pharmacist’s perspective Dr David Alldred Senior Lecturer in Pharmacy Practice 23 January 2015Bradford School of Pharmacy1.
Lucy Alexakis & Kate Clarke Medication Review Pharmacists Shaping healthcare for you … and your family.
Frail Elderly Pathway Walsall Healthcare NHS Trust.
Training Primary Care Pharmacists Paula Wilkinson Chief Pharmacist Mid-Essex CCG.
Have your say on our plans for Primary Care in Warrington.
2015/16 NHS Pre-registration Trainee Pharmacist Programme Proposed Themes The Programme will consist of 4 interconnecting themes with emphasis on direct.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Dr Mary Backhouse Chief Clinical Officer Our ‘Big Questions’
Hallmark Health System October 11, 2011 Founded as a system in 1997, Hallmark Health is a local, not for profit, community based healthcare system serving.
Older People’s Services The Single Assessment Process.
Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Medicines Optimisation Polypharmacy and Deprescribing
The Safe Management of Medicines in Adult Social Care Settings Stephanie West MRPharmS CQC Pharmacist Specialist.
Commissioning Integrated Rehabilitation and Re-ablement Services? Cath Attlee and Ray Boateng 1.
Medicines Reconciliation A Whole System Approach Arlene Coulson Principal Clinical Pharmacist, Specialist Services Gordon Thomson Principal Clinical Pharmacist,
STACCATO Stow Anticipatory Care Community Assessment Tool Dr Paul Cormie Sandra Pratt NHS Borders.
Readmissions Driver Diagram OHA HEN 2.0. Readmissions AIMPrimary Drivers Secondary DriversChange Ideas Reduce Readmissions Identify patients at high-risk.
Alison Blenkinsopp Professor of the Practice of Pharmacy University of Bradford School of Pharmacy.
E n h a n c e d h e a l t h i n c a r e h o m e s Rachel Binks, Nurse Consultant - Acute and Digital Care Airedale NHSFT The Art of the Possible - Enabling.
Pharmacy Service role in supporting informal carers Inverclyde Pharmacy Change Plan Natalie O’Gorman.
Educational solutions for the NHS pharmacy workforce Medicines Optimisation: Helping patients to make the most of medicines Sue Carter Regional Tutor
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
Discharge Medicines Review Service. Potted history of the Service April 2011: Health Minister agrees funding for new community pharmacy service in Wales.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
Introduction to the Gold Standards Framework Domiciliary Care Training Programme Maggie Stobbart-Rowlands, Lead Nurse, GSF Central Team.
We’re counting the benefits of EPR Find out at: epr.this.nhs.uk We’re counting the benefits of EPR Find out at: epr.this.nhs.uk The introduction of EPR.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
Private and confidential Community Pharmacy Future Four-or-more medicines support service Update on progress and next steps Approved18 th June 2012 This.
European Community Pharmacy Blueprint A perspective from general practice Professor Tony Avery.
Improving medicines adherence and reducing medicines waste: EAHSN/PrescQIPP- Strategy to develop joint working programme with the Pharmaceutical.
Pharmacy White Paper Building on Strengths Delivering the Future Overview.
Medication Reconciliation ROP Compliance
Medicines Optimisation
MOCH (Medicines Optimisation in Care Homes) Pharmacists
Medicines Safety Programme
Claire Vaughan- Head of Medicines Optimisation, Salford CCG
Medicines in Adult Social Care Care homes & Care at Home
Clair Huckerby Consultant Pharmacist
Medicines.
Presentation transcript:

Discharge planning – reducing admissions/re- admissions Jo Clarke, CPPE tutor 1

Housekeeping 2 Comfortable See and hear Fire alarm & exits Toilets Phones and devices Evaluation forms

Aim 3 To provide learners with a better understanding of how, by making transfer of care safer and more effective on discharge from hospital, pharmacy teams can improve patient outcomes and reduce hospital admissions.

Learning objectives 4 On completion of this workshop you should be able to: describe the potential impact of poor transfer of care on discharge from hospital on patients and the health service as a whole identify steps in the discharge process where pharmacy professionals can improve transfer of care for patients identify patients who may benefit from advance planning for discharge due to pharmaceutical care issues outline a ‘transfer-of-care friendly’ discharge summary

What’s the problem? 5  There is a less than 10 percent likelihood that an elderly medical patient will be discharged on the same medicines that they were admitted on.  Approximately 45 percent of medicines prescribed at discharge are new for that patient.  Around 60 percent of patients will have three or more medicines changed during their hospital stay.  Unintended discrepancies in medicines after discharge from hospital affect up to 87 percent of patients.

NHS England safety alert Aug 14 6 Risks arising from breakdown and failure to act on communication during handover at the time of discharge from secondary care Communication on handover accounts for approx 33% of the 10,000 reported toNRLS National workstream part of Patient Safety Domain at NHS England

What does this mean for patients and the NHS? 7  Safety and quality of care  Waste  Adverse drug events

Poor discharge examples 8 Watch this video clip of a GP describing two problematic discharges which had an impact on patient care. Think about what you or another pharmacy professional could have done to improve the outcomes for these patients Video clip

What could have prevented these problems? 9 Discussion on the key points / what could have been done? Examples from others where admissions have been potentially avoided – discuss in small groups and then be prepared to feedback

Transition from hospital to community 10  How can this transition be safe and well managed?  Discharge planning – which patients need advance planning due to pharmaceutical care issues?  Are local drug charts and discharge summaries transfer-of- care friendly? How can they be improved?  Routine referral of patients to their community pharmacist for post-discharge support – Hospital referral to community pharmacy: An innovator’s toolkit from the RPS and NHS PrescQIPP webkitHospital referral to community pharmacy: An innovator’s toolkitNHS PrescQIPP webkit  Is additional support available for high-risk groups post- discharge? Is this part of commissioning plans? How will you identify and prioritise those at risk of re-admission?

Prior to admission 11 What is our role in primary care? Discuss in small groups What can we do to improve information to hospitals on admission? Consider summary care records, doses eg insulin / warfarin and problems / solutions

On admission or first contact 12 The pharmacy team provides the leadership, systems support and expertise that enables a multidisciplinary team to identify potential medicines problems affecting discharge (or transfer to another care setting) so that they can be accommodated to avoid extending patients’ stays in hospital’.

Discharge planning 13  Are you based in your GP practice all or most of the time?  Does your hospital pharmacy know of your role?  Suggest they do so that they can contact you for patients being discharged who are at-risk of medicines-related issues.

Discharge planning 14  Adherence concerns  Patients using MCAs  Other concordance support required  Swallowing difficulties/NG/PEG  Children on unlicensed medicines  Home care  Shared care required  Unlicensed specials  PREVENT referral tool

Multi-compartment compliance aids (MCAs) 15  Is the patient actually able to use the MCA? Is the MCA for the patient or to support the carer?  What is the hospital policy on starting a patient on a MCA or filling one they have brought in?  Is there local agreement on medicines that should not normally be stored in a MCA?  Does the patient need additional support to use the MCA eg, large- print labels?

Multi-compartment compliance aids (MCAs) 16  Is there local agreement on the inclusion of high risk medicines such as warfarin or lithium in MCAs?  What is the local social services policy in terms of care workers prompting patients to take their medicines from normal packaging versus MCAs?

Communication 17  Are local drug charts and discharge summaries transfer-of-care friendly?  How can they be improved? Who can you talk to about this?  Take 5 mins to look at this example of an electronic discharge summary – identify 5 changes you could make to improve the transfer of information about medicines.

Referral for dMUR/NMS 18  How can you support the hospital team to refer for dMUR/NMS? Are there projects in your area?  RPS toolkit - support-resources/referral-toolkit.asphttp:// support-resources/referral-toolkit.asp  NHS PrescQIPP Transfer of Care webkit - community-pharmacy community-pharmacy  Working with GPs and understanding their challenges regarding interface

Additional support for high risk groups? 16 NICE guideline 5 – Medicines optimisation: Organisations should consider arranging additional support for some groups of people when they have been discharged from hospital, such as pharmacist counselling, telephone follow-up, and GP or nurse follow-up home visits. These groups may include: Adults, children and young people taking multiple medicines (polypharmacy) Adults, children and young people with chronic or long-term conditions Older people

Consultation skills 20  Every time we have an interaction with a patient  National Standards for pharmacy professionals  Patient-centred  Shared decision making

Resources 21

Resources 22   Specialist pharmacy services - ies/NHS/SPS-E-and-SE-England/ ies/NHS/SPS-E-and-SE-England/  CPPE e-learning programme – Transfer of care: supporting patients moving into and out of hospital - – section 3 describes range of resources available to support good transfer of care

Follow us on Twitter, Facebook, LinkedIn and YouTube: